Newport Beach, California (PRWEB) October 03, 2013
Publicly traded company Vestiage, symbol "VEST", has announced the acquisition of two trademarks, "Shave Clean" and "Face Guard" today from Boston, Massachusetts based entrepreneur, John P. Walsh.
Scott Kimball, CEO of Vestiage, stated, "We believe these two trademarks to be of great value to us as we grow our portfolio of brands and associated intellectual property. We have several R&D projects ahead of us in the skin care arena to complement our Reluma line of products, but we also see the opportunity and potential of extending the RegiMEN™ brand to skin care for men using these trademarks. We are in discussions with nano-technology delivery systems that are applicable to skin care and the opportunity exists for us to combine this technology with a product and use the trademarks in that combination. In the future we may extend the Monterey Bay Nutraceuticals line to include an anti-aging natural shave product for women using "Shave Clean" or a sunscreen based anti-aging After Shave balm using the "Face Guard" name for men using the RegiMEN™ brand. There are a lot of possibilities."
Chief Operating Officer, Garrett Heiser stated, "Vestiage has recently been moving very quickly, signing endorsement agreements, adding brands through acquisition, launching new brands that we have formulated and created, and starting R&D for new brands such as that with Dara Torres. Our methodology in creating a brand and the products is radically different than the industry norm. Most people don't know how we approach the creative process. Instead of the norm, which is to formulate with a market and price point in mind, we do the opposite. We formulate and create a product with the goal to make it so cool that the market doesn't even know they want it yet. Obviously we know the market demand, but we tell our scientists and formulators and partners to forget the retail price point and create the dream product. Use your dream science-based ingredients. Forget the expense of the ingredients. Ask how we can make something incredible without those normal constraints. Then we keep it simple. We make the formula elegant, pure, clean, simple and potent."
In April 2013 Vestiage partnered with Dara Torres, the Olympic Champion, in an endorsement deal that also included the eventual formulation and release of a Dara Torres signature line of performance oriented supplements and other products for the active woman. On August 30, 2013 it announced the closing of the RegiMEN brand anti-aging system for men currently sold at select GNC, Complete Nutrition, and Smoothie King stores. On September 30 the Company acquired the "Shave Clean" and "Face Guard" trademarks. On October 1, Vestiage gave the go-ahead to its production partner Robinson Pharma to launch the Monterey Bay Nutraceuticals brand with its first commercial run of product for distributors and retailers samples and initial inventory for online and direct response sales.
Vestiage (stock symbol "VEST") is a publicly traded anti-aging lifestyle company offering premium branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the mission of extending the quality of and active life using human stem cell, marine/ocean, and cutting edge botanically based science and patented botanical ingredients to produce pure, highly potent and effective products. Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com) and RegiMEN™. Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on extending the quality of an active life and human performance science that covers both the cognitive and physical realms. As clinical results validate scientific discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across its brands. To learn more, visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiency and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.